Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men.

Tremblay AJ, Lamarche B, Lemelin V, Hoos L, Benjannet S, Seidah NG, Davis HR Jr, Couture P.

J Lipid Res. 2011 Mar;52(3):558-65. doi: 10.1194/jlr.M011080. Epub 2010 Dec 1.

2.

High doses of atorvastatin and simvastatin induce key enzymes involved in VLDL production.

Roglans N, Verd JC, Peris C, Alegret M, Vázquez M, Adzet T, Díaz C, Hernández G, Laguna JC, Sánchez RM.

Lipids. 2002 May;37(5):445-54.

PMID:
12056585
3.

Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.

Burnett JR, Wilcox LJ, Telford DE, Kleinstiver SJ, Barrett PH, Newton RS, Huff MW.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2589-600.

4.
5.

Atorvastatin increases expression of low-density lipoprotein receptor mRNA in human circulating mononuclear cells.

Pocathikorn A, Taylor RR, Mamotte CD.

Clin Exp Pharmacol Physiol. 2010 Apr;37(4):471-6. doi: 10.1111/j.1440-1681.2009.05337.x. Epub 2009 Nov 23.

PMID:
19930424
6.

Sitosterol reduces messenger RNA and protein expression levels of Niemann-Pick C1-like 1 in FHs 74 Int cells.

Jesch ED, Seo JM, Carr TP, Lee JY.

Nutr Res. 2009 Dec;29(12):859-66. doi: 10.1016/j.nutres.2009.10.016.

PMID:
19963159
7.

Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity.

Ness GC, Chambers CM, Lopez D.

J Lipid Res. 1998 Jan;39(1):75-84.

8.

Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects.

Cilla DD Jr, Whitfield LR, Gibson DM, Sedman AJ, Posvar EL.

Clin Pharmacol Ther. 1996 Dec;60(6):687-95.

PMID:
8988072
9.

Ezetimibe increases intestinal expression of the LDL receptor gene in dyslipidaemic men with insulin resistance.

Drouin-Chartier JP, Tremblay AJ, Lemelin V, Lépine MC, Lamarche B, Couture P.

Diabetes Obes Metab. 2016 Dec;18(12):1226-1235. doi: 10.1111/dom.12749. Epub 2016 Aug 31.

PMID:
27460541
10.

Attenuation of contractile dysfunction by atorvastatin after intestinal ischemia reperfusion injury in rats.

Ozacmak VH, Sayan H, Igdem AA, Cetin A, Ozacmak ID.

Eur J Pharmacol. 2007 May 7;562(1-2):138-47. Epub 2007 Feb 8.

PMID:
17335801
11.

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.

Youssef S, Stüve O, Patarroyo JC, Ruiz PJ, Radosevich JL, Hur EM, Bravo M, Mitchell DJ, Sobel RA, Steinman L, Zamvil SS.

Nature. 2002 Nov 7;420(6911):78-84.

PMID:
12422218
12.

Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback regulation.

Chen Y, Ku H, Zhao L, Wheeler DC, Li LC, Li Q, Varghese Z, Moorhead JF, Powis SH, Huang A, Ruan XZ.

Arterioscler Thromb Vasc Biol. 2014 Feb;34(2):365-76. doi: 10.1161/ATVBAHA.113.301301. Epub 2013 Nov 14.

13.
15.

Polyphenol-rich black chokeberry (Aronia melanocarpa) extract regulates the expression of genes critical for intestinal cholesterol flux in Caco-2 cells.

Kim B, Park Y, Wegner CJ, Bolling BW, Lee J.

J Nutr Biochem. 2013 Sep;24(9):1564-70. doi: 10.1016/j.jnutbio.2013.01.005. Epub 2013 Mar 18.

PMID:
23517916
16.
17.

Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux.

Argmann CA, Edwards JY, Sawyez CG, O'Neil CH, Hegele RA, Pickering JG, Huff MW.

J Biol Chem. 2005 Jun 10;280(23):22212-21. Epub 2005 Apr 6.

18.

Down-regulation of ABCB1 transporter by atorvastatin in a human hepatoma cell line and in human peripheral blood mononuclear cells.

Rodrigues AC, Curi R, Britto LR, Rebbechi IM, Hirata MH, Bertolami MC, Bernik MM, Dorea EL, Hirata RD.

Biochim Biophys Acta. 2006 Dec;1760(12):1866-73. Epub 2006 Aug 8.

PMID:
16996216
19.

Changes in intestinal and liver global gene expression in response to a phytosterol-enriched diet.

Calpe-Berdiel L, Escolà-Gil JC, Ribas V, Navarro-Sastre A, Garcés-Garcés J, Blanco-Vaca F.

Atherosclerosis. 2005 Jul;181(1):75-85. Epub 2005 Feb 12.

PMID:
15939057
20.

Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response.

Arazi SS, Genvigir FD, Willrich MA, Hirata MH, Dorea EL, Bernik M, Hirata RD.

Clin Chim Acta. 2008 Jul 17;393(2):119-24. doi: 10.1016/j.cca.2008.03.031. Epub 2008 Apr 8.

PMID:
18435918

Supplemental Content

Support Center